6Bowman C,Ambrus K,Lockwood CM,et al.Restriction of human IgG subclass expression in the population of auto-antibodies to glomerular basement membrane[J].Clin Exp Immunol,1987,69:343-349.
7Dagan R, Klugman KP, Craig WA, et al.Evidence to sup- port the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy [J].JAntimocrob Chemother, 2001,47 ( 2 ) : 129.
8Cazzola M, Di Perna F, Boveri B, et al.Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute ex- acetbation of chronic bronchitis[J].J Chemother, 2000, 12 (3):216.
9Craig WA.The hidden impact of antibacterial resistance in respiratory tract infection. Re-evaluating current antibiot- ic therapy[J].Respir Med, 2001,95 (Suppl A ) : 12.
10Frimodt-Moller N.How predictive is PK/PD for antibacte- rial agents?[J]. IntJAntimicrobAgents,2002,19(4) :333.
